Blog

VANCOUVER, BC / ACCESS Newswire / October 22, 2025 / Revolve Renewable Power Corp. (TSXV:REVV)(OTCQB:REVVF) (“Revolve” or the “Company“), a North American owner, operator and developer of renewable energy projects, reported its financial results for the year ended June 30, 2025 (“FY2025”). This earnings release should be read in conjunction with the Company’s consolidated financial statements and management’s discussion and analysis, which are available on the Company’s website at www.revolve-renewablepower.com and have been posted on SEDAR+ at www.sedarplus.ca. All amounts reported are in US dollars.

“Revolve recorded a 73% increase in recurring revenue from our 13-megawatt (“MW”) portfolio of operating assets while making key investments in the continued development of our project pipeline,” said CEO Myke Clark. “Our team continued to make significant progress on and investments into our pipeline of late-stage development projects with the goal of creating long-term value for shareholders. This revenue model – combining a growing recurring revenue stream with large project development – provides a stable foundation for growth.”

Key financial highlights (all figures reported in USD)

• Total recurring revenue from operating assets of $2,241,357, an increase of 73% from recurring revenue of $1,292,297 in FY2024.

• Total revenue of $3,983,226 for FY2025, compared to total revenue of $6,742,297 in FY2024. The decrease in total revenue is attributable to deferred consideration payments received in FY2024 from the ENGIE Bouse & Parker project sale transaction, which were not a feature of the FY2025 financials.

• Net loss for FY2025 of $2,590,122, compared to net income of $2,602,510 in FY2024 as the Company continued to make key investments in its portfolio of late-stage development projects.

• Energy Production of 15,747,489 kWh from operating assets compared to 8,616,916 kWh in FY2024, an increase of 83%.

• Gross profit of $ 3,238,341, representing a gross profit margin of 81%. Gross profit decreased from $6,386,416 in the comparative period in F2024 due to the decrease in milestone payments from project asset sales.

• Cash and security deposits on the balance sheet as at June 30, 2025, was $1,950,895.

Key business highlights

Develop, Own & Operate – Revolve develops, builds, owns and operates smaller utility scale projects as well as distributed generation projects to generate recurring revenue. This revenue stream, supported by a 13 MW operating portfolio, benefited from the full year impact of the Windriver Power Corporation acquisition in 2024 and the addition of the Colima Distributed Generation (“DG”) project in Mexico. These projects, in addition to the Company’s portfolio of operating DG projects in Mexico, form Revolve’s stable platform for future growth based on long-life, contracted renewable energy assets. Revolve made strong progress on the late stage 20 MW Vernal Battery Energy Storage System (“BESS”) development project in Utah, the 50 MW Primus Wind Project in Colorado and the 15.7 MW Bright Meadows solar project in Alberta, Canada.

Develop & Sell – Revolve develops large utility scale projects from greenfield to ready-to-build, at which point it sells the development rights to large utilities and independent power producers. The Company has benefited from the proceeds received during FY2023 and FY2024 from the sale of the Bouse & Parker solar and storage projects totaling 1,250 MW to ENGIE, which totalled $6.25m during these periods. Revenues from transactions such as this are difficult to predict in terms of timing and there were no payments received from the ENGIE transaction in FY2025. The Company remains optimistic that the remaining milestone payments from the ENGIE transaction, equating to between $40,000-$50,000 per MW, will be received in future periods.

During FY2025, the Company also made progress across several other projects in its Develop & Sell portfolio, in particular over 500MW of wind projects in Mexico. The Company’s decision to continue to invest in the development of these projects during FY2025 has placed the company in a good position as the Mexican government ramps up private sector investment in the renewable energy sector. By holding these assets through key de-risking milestones, Revolve is positioned to benefit from enhanced project valuations and a stronger overall portfolio that aligns with the Company’s long-term growth strategy. The Company continues to actively review and consider partnership and monetisation opportunities for these projects. Revolve also completed the sale of the Afton Solar & Storage project during the period, which was an early stage development project in the US.

During FY2025 and subsequent to the fiscal year-end, Revolve completed several transactions and achieved multiple project milestones across its development portfolio:

• Revolve Expands Mexico Distributed Generation Business with New Partnership. On October 9, 2025, Revolve announced it has signed a partnership agreement dated October 8, 2025 with an experienced Engineer, Procure and Construct company (the “EPC Partner”) in Mexico to develop and build a new portfolio of distributed generation power solutions for commercial and industrial customers, targeting two initial portfolios of commercial projects totaling more than 5 MW of capacity. The EPC Partner has previously developed more than 50 MW of distributed generation solar projects and brings valuable expertise to the partnership.

• Revolve Receives Approval from the Alberta Utilities Commission for the 15.7 MW Bright Meadows Solar Project. On September 15, 2025, Revolve, announced that its wholly-owned subsidiary, Revolve Meadows Solar GP Inc., has received Power Plant Approval (Decision 29985-D01-2025) from the Alberta Utilities Commission (“AUC”) Bright Meadows Solar Project (“Bright Meadows Project”). Located in in the County of Wetaskiwin, Alberta, approximately 80 km south of Edmonton, the Bright Meadows Project is a 15.7 MW solar power project that will generate enough renewable electricity to power more than 3,700 homes once operational. AUC approval is the key regulatory permit required for the Bright Meadows Solar Project and we are now moving forward on the final interconnection and construction planning for this project. Revolve would like to thank the County of Wetaskiwin, the local community and our partners for their support through the AUC process.

• Revolve Signs Agreement to Acquire 30 MWp Solar Project in Canada. As announced on September 22, 2025, the Company has entered into a binding Letter of Intent (“LOI”) to acquire the assets related to the Project and will enter into an asset transfer agreement (“ATA”), subject to certain customary closing conditions. Following the AUC permit approval for the Company’s 15.7 MW Bright Meadows solar project, the Company has moved to secure a further late-stage development project in the province. The current intention is to have the Bright Meadows project ready to build and under construction in 2026, which will be followed by this 30 MWp project in 2027 creating a consistent pipeline of ‘Develop and Build’ projects in Canada.

• CHP Project Asset Sale Transaction. On February 18, 2025, the Company announced the sale of a 3 MW combined heat and power project (the “CHP Project”) from its distributed generation portfolio for total cash consideration of $1.5 million. The CHP Project was originally acquired by Revolve in August 2022 as part of the $1.4m acquisition of Centrica Business Solutions Mexico S.A. de C.V. Revolve regularly assesses its assets to determine optimal capital allocation – in the case of the CHP Project, the Company took the opportunity to monetize this asset and reinvest that capital into higher return near-term opportunities.

The Company also announces the grant of Deferred Share Units (“DSUs”) to Company directors effective October 22, 2025. A total of 401,585 DSU’s have been granted under the Company’s Deferred Share Unit Plan adopted on July 6, 2022. Each DSU entitles the holder to receive one share of the Company, or in certain circumstances a cash payment equal to the value of one share of the Company, at the time the holder ceases their position with the Company. The DSUs vest one year from the date of grant. The DSUs were granted for Q4 F2025 at a price of C$0.23 per share. The Company issues DSUs at the end of each quarter in lieu of cash director’s fees to preserve working capital for project development initiatives.

For further information contact:
Myke Clark, CEO
IR@revolve-renewablepower.com
778-946-0072

About Revolve
Revolve was formed in 2012 to capitalize on the growing global demand for renewable power. Revolve develops utility-scale wind, solar, hydro and battery storage projects in the US, Canada and Mexico. Revolve also installs and operates sub 20MW “behind the meter” distributed generation (or “DG”) assets. Revolve’s portfolio includes the following:

• Operating Assets: 13 MW (net) of operating assets under long term power purchase agreements across Canada and Mexico covering wind, solar, battery storage and hydro generation;

• Development: a diverse portfolio of utility scale development projects across the US, Canada and Mexico with a combined capacity of over 3,000MWs as well as a 140MW+ distributed generation portfolio that is under development.

Revolve has an accomplished management team with a demonstrated track record of taking projects from “greenfield” through to “ready to build” status and successfully concluding project sales to large operators of utility-scale renewable energy projects. To-date, Revolve has developed and sold over 1,550MW of projects.

Going forward, Revolve is targeting 5,000MW of utility-scale projects under development in the US, Canada and Mexico, and in parallel is rapidly growing its portfolio of revenue-generating DG assets.

Forward Looking Information
The forward-looking statements contained in this news release constitute ‘‘forward-looking information” within the meaning of applicable securities laws in each of the provinces and territories of Canada and the respective policies, regulations and rules under such laws and ‘‘forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 (collectively, ‘‘forward-looking statements”). The words “will”, “expects”, “estimates”, “projections”, “forecast”, “intends”, “anticipates”, “believes”, “targets” (and grammatical variations of such terms) and similar expressions are often intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements in this press release include statements regarding the Company’s project development and construction timelines, regulatory approvals, asset acquisitions and sales, strategic partnerships, expected energy production, and the advancement and monetization of its project pipeline. This forward-looking information and other forward-looking information are based on our opinions, estimates and assumptions considering our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we currently believe are appropriate and reasonable in the circumstances. Despite a careful process to prepare and review the forward-looking information, there can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct. Material factors underlying forward-looking information and management of the Company’s (“Management“) expectations include: the receipt of applicable regulatory approvals; the absence of material adverse regulatory decisions being received and the expectation of regulatory stability; the absence of any material equipment breakdown or failure; availability of financing on commercially reasonable terms and the stability of credit ratings of the Company and its subsidiaries; the absence of unexpected material liabilities or uninsured losses; the continued availability of commodity supplies and stability of commodity prices; the absence of interest rate increases or significant currency exchange rate fluctuations; the absence of significant operational, financial or supply chain disruptions or liability, including relating to import controls and tariffs; the continued ability to maintain systems and facilities to ensure their continued performance; the absence of a severe and prolonged downturn in general economic, credit, social or market conditions; the successful and timely development and construction of new projects; the absence of capital project or financing cost overruns; sufficient liquidity and capital resources; the continuation of long term weather patterns and trends; the absence of significant counterparty defaults; the continued competitiveness of electricity pricing when compared with alternative sources of energy; the realization of the anticipated benefits of the Company’s acquisitions and joint ventures; the absence of a change in applicable laws, political conditions, public policies and directions by governments, materially negatively affecting the Company; the ability to obtain and maintain licenses and permits; maintenance of adequate insurance coverage; the absence of material fluctuations in market energy prices; the absence of material disputes with taxation authorities or changes to applicable tax laws; continued maintenance of information technology infrastructure and the absence of a material breach of cybersecurity; the successful implementation of new information technology systems and infrastructure; favourable relations with external stakeholders; our ability to retain key personnel; our ability to maintain and expand distribution capabilities; and our ability to continue investing in infrastructure to support our growth.

These and other uncertainties and risks could cause actual results to differ materially from those expressed or implied by the forward-looking statements or to cause the underlying assumptions to prove incorrect. Such uncertainties and risks may include, among others, market conditions, delays in obtaining or failure to obtain required regulatory approvals in a timely fashion, or at all; the availability of financing, fluctuating prices, the possibility of project cost overruns, mechanical failure, unavailability of parts and supplies, labour disturbances, interruption in transportation or utilities, adverse weather conditions, and unanticipated costs and expenses, variations in the cost of energy or materials or supplies or environmental impacts on operations, disruptions to the Company’s supply chains; changes to regulatory environment, including interpretation of production tax credits; armed hostilities and geopolitical conflicts; risks related to the development and potential development of the Company’s projects; conclusions of economic evaluations; changes in project parameters as plans continue to be refined; the availability of tax incentives in connection with the development of renewable energy projects and the sale of electrical energy; as well as those factors discussed in the sections relating to risk factors discussed in the Company’s continuous disclosure filings on SEDAR+ at sedarplus.ca. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Readers are cautioned that given these risks, undue reliance should not be placed on these forward-looking statements, which apply only as of their dates.

Future-oriented financial information (“FOFI“) and financial outlooks contained in this release, including statements regarding estimated capital expenditures, anticipated milestone payments, and projected financial outcomes from project sales or partnerships and, are provided for illustrative purposes only and are subject to the same assumptions, risk factors, and uncertainties described above with respect to forward-looking information. Such FOFI reflects Management’s current estimates and assumptions considered reasonable in the circumstances, which may prove incorrect. Actual financial results may differ materially from Management’s expectations, and such variations may be material and adverse. The Company’s financial projections are inherently speculative, were not prepared with a view toward compliance with applicable GAAP and have not been reviewed or audited by independent accountants or other third-party experts, and should not be relied upon as indicative of future results. Such information is presented for illustrative purposes only and may not be an indication of our actual financial position or results of operations.

Other than as specifically required by law, the Company undertakes no obligation to update any forward-looking statements or FOFI to reflect new information, subsequent or otherwise. The Company does not intend, and expressly disclaims any intention or obligation to, update or revise any forward-looking statements or FOFI whether because of new information, future events or otherwise, except as required by law.

“Neither TSX Venture Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.”

SOURCE: Revolve Renewable Power Corp.

View the original press release on ACCESS Newswire

HOUSTON, TEXAS / ACCESS Newswire / October 17, 2025 / XCF Global, Inc. (“XCF”) (Nasdaq:SAFX), a key player in decarbonizing the aviation industry through Sustainable Aviation Fuel (“SAF”), today announces that it has filed its Quarterly Report on Form 10-Q for the period ended June 30, 2025, with the U.S. Securities and Exchange Commission (“SEC”).

As a result of the filing, the company has regained compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the SEC.

The Form 10-Q is available on the SEC’s website at www.sec.gov.

About XCF Global, Inc.

XCF Global, Inc. is a pioneering sustainable aviation fuel company dedicated to accelerating the aviation industry’s transition to net-zero emissions. XCF is developing and operating state-of-the-art clean fuel SAF production facilities engineered to the highest levels of compliance, reliability, and quality. The company is actively building partnerships across the energy and transportation sectors to accelerate the adoption of SAF on a global scale. XCF is listed on the Nasdaq Capital Market and trades under the ticker, SAFX. Current outstanding shares: ~159.2 million; <20% free float (as of October 17, 2025).

To learn more, visit www.xcf.global.

Contacts

XCF Global:
C/O Camarco
XCFGlobal@camarco.co.uk

Media:

Camarco
Andrew Archer | Rosie Driscoll | Violet Wilson
XCFGlobal@camarco.co.uk

Forward Looking Statements

This Press Release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or the negatives of these terms or variations of them or similar terminology. These forward-looking statements, including, without limitation, statements regarding XCF Global’s expectations with respect to future performance and anticipated financial impacts of the recently completed business combination with Focus Impact BH3 Acquisition Company (the “Business Combination”), estimates and forecasts of other financial and performance metrics, and projections of market opportunity and market share, are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by XCF Global and its management, are inherently uncertain and subject to material change. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) changes in domestic and foreign business, market, financial, political, and legal conditions; (2) unexpected increases in XCF Global’s expenses, including manufacturing and operating expenses and interest expenses, as a result of potential inflationary pressures, changes in interest rates and other factors; (3) the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any agreements with regard to XCF Global’s offtake arrangements; (4) the outcome of any legal proceedings that may be instituted against the parties to the Business Combination or others; (5) XCF Global’s ability to regain compliance with Nasdaq’s continued listing standards and thereafter continue to meet Nasdaq’s continued listing standards; (6) XCF Global’s ability to integrate the operations of New Rise and implement its business plan on its anticipated timeline; (7) XCF Global’s ability to raise financing to fund its operations and business plan and the terms of any such financing; (8) the New Rise Reno production facility’s ability to produce the anticipated quantities of SAF without interruption or material changes to the SAF production process; (9) the New Rise Reno production facility’s ability to produce renewable diesel in commercial quantities without interruption during the ongoing SAF ramp-up process; (10) XCF Global’s ability to resolve current disputes between its New Rise subsidiary and its landlord with respect to the ground lease for the New Rise Reno facility; (11) XCF Global’s ability to resolve current disputes between its New Rise subsidiary and its primary lender with respect to loans outstanding that were used in the development of the New Rise Reno facility; (12) payment of fees, expenses and other costs related to the completion of the Business Combination and the New Rise acquisitions; (13) the risk of disruption to the current plans and operations of XCF Global as a result of the consummation of the Business Combination; (14) XCF Global’s ability to recognize the anticipated benefits of the Business Combination and the New Rise acquisitions, which may be affected by, among other things, competition, the ability of XCF Global to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (15) changes in applicable laws or regulations; (16) risks related to extensive regulation, compliance obligations and rigorous enforcement by federal, state, and non-U.S. governmental authorities; (17) the possibility that XCF Global may be adversely affected by other economic, business, and/or competitive factors; (18) the availability of tax credits and other federal, state or local government support; (19) risks relating to XCF Global’s and New Rise’s key intellectual property rights, including the possible infringement of their intellectual property rights by third parties; (20) the risk that XCF Global’s reporting and compliance obligations as a publicly-traded company divert management resources from business operations; (21) the effects of increased costs associated with operating as a public company; and (22) various factors beyond management’s control, including general economic conditions and other risks, uncertainties and factors set forth in XCF Global’s filings with the Securities and Exchange Commission (“SEC”), including the final proxy statement/prospectus relating to the Business Combination filed with the SEC on February 6, 2025, this Press Release and other filings XCF Global made or will make with the SEC in the future. If any of the risks actually occur, either alone or in combination with other events or circumstances, or XCF Global’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that XCF Global does not presently know or that it currently believes are not material that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect XCF Global’s expectations, plans or forecasts of future events and views as of the date of this Press Release. These forward-looking statements should not be relied upon as representing XCF Global’s assessments as of any date subsequent to the date of this Press Release. Accordingly, undue reliance should not be placed upon the forward-looking statements. While XCF Global may elect to update these forward-looking statements at some point in the future, XCF Global specifically disclaims any obligation to do so.

SOURCE: XCF Global, Inc.

View the original press release on ACCESS Newswire

Reels to strengthen operational execution and expand U.S.-based manufacturing capacity for defense and enterprise markets

ORLANDO, FLORIDA / ACCESS Newswire / October 20, 2025 / Unusual Machines (NYSE AMERICAN:UMAC), a leading provider of NDAA-compliant drone components, today announced the appointment of Jason Reels as Vice President of Supply Chain. Reels will report to Chief Operating Officer Andrew Camden and lead Unusual Machines’ global supply chain operations as the company expands production capacity across its U.S. facilities.

Reels will oversee inbound logistics, materials management, and fulfillment to improve speed, coordination, and throughput as the company scales motor and headset production to meet growing defense and enterprise demand.

“Operating a disciplined and efficient supply chain is the backbone of our ability to deliver,” said Andrew Camden, COO of Unusual Machines. “Jason’s experience leading complex logistics networks and scaling production across multiple regions will strengthen our execution as we continue expanding domestic manufacturing.”

Reels brings more than 15 years of experience across the automotive, manufacturing, and technology sectors, building multi-site supply chains in North America, Mexico, and Asia, and implementing ERP and warehouse systems aligned with NetSuite. His background supports Unusual Machines’ continued emphasis on reliability, compliance, and speed within its production network.

“We’re building for scale in a way that keeps control and quality front and center,” said Jason Reels. “I’m focused on building the systems and teams that keep production moving at the speed our customers have come to expect from Unusual Machines.”

About Unusual Machines

Unusual Machines manufactures and sells drone components and drones across a diversified brand portfolio, which includes Fat Shark, the leader in FPV (first-person view) ultra-low latency video goggles for drone pilots. The Company also retails small, acrobatic FPV drones and equipment directly to consumers through the curated Rotor Riot ecommerce store. With a changing regulatory environment, Unusual Machines seeks to be a dominant Tier-1 parts supplier to the fast-growing multi-billion-dollar U.S. drone industry. According to Fact.MR, the global drone accessories market is currently valued at $17.5 billion and is set to top $115 billion by 2032.

For more information, please visit www.unusualmachines.com.

Investor Contact

CS Investor Relations
investors@unusualmachines.com

Media Contact

media@unusualmachines.com

SOURCE: Unusual Machines, Inc.

View the original press release on ACCESS Newswire

Company to discontinue development of mRNA-1647 in congenital CMV

Company will continue to evaluate mRNA-1647 in ongoing Phase 2 trial in bone marrow transplant patients

Company does not anticipate any impact to its 2025 financial guidance or its expectation of achieving breakeven in 2028

CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company’s investigational cytomegalovirus (CMV) vaccine. The study did not meet its primary efficacy endpoint of preventing CMV infection in seronegative female participants of childbearing age (16-40 years of age). Moderna will discontinue its congenital CMV clinical development program.

“Today’s announcement is disappointing for families and healthcare professionals who have been eagerly awaiting a CMV vaccine to prevent congenital CMV, a leading infectious cause of birth defects,” said Stéphane Bancel, Chief Executive Officer of Moderna. “The majority of the data from this trial is still forthcoming, and we will share our full results with the scientific community in hopes that our learnings can contribute to the continued pursuit of a CMV vaccine. I am grateful for our dedicated team, our partners at clinical trial sites, and all the trial participants who made this research possible.”

The Phase 3 trial (NCT05085366) was a randomized, observer-blind, placebo-controlled study. The study included approximately 7,500 women 16-40 years of age from approximately 300 sites across 13 countries, representing the largest trial assessing the efficacy of a CMV vaccine to-date. Vaccine efficacy against primary CMV infection in healthy women was well below the Company’s target, ranging from 6% to 23% depending on the case definition used.

“We are clearly disappointed by the failure to prevent primary infection because it means there is still no vaccine for the prevention of congenital CMV despite the many decades of work by the field,” said Stephen Hoge, MD, President of Moderna. “CMV does cause significant disease in other contexts, including reactivation of the latent virus in those undergoing bone marrow transplantation, and we will continue to explore the potential of mRNA-1647 to suppress disease associated with reactivation in those high-risk patients through our ongoing Phase 2 study.”

mRNA-1647 was found to be generally well-tolerated regardless of CMV serostatus, with a safety profile consistent with earlier studies. No safety concerns have been raised by the Data and Safety Monitoring Board. The Company plans to continue its study of mRNA-1647 in bone marrow transplant patients, which is currently in a Phase 2 trial (NCT05683457).

Moderna does not anticipate any impact to its 2025 financial guidance or its expectation of achieving breakeven in 2028. Moderna anticipated minimal initial revenue contribution from mRNA-1647 given necessary investments in market building and launch, and expected the product to be cash-flow negative in 2028.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including pioneering work on COVID-19 vaccines.

Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: Moderna’s 2025 financial guidance and its expectation of achieving breakeven in 2028; and the potential of mRNA-1647 for bone marrow transplant patients and Moderna’s ongoing Phase 2 trial. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.

Moderna Contacts

Media:

Chris Ridley
Head of Global Media Relations
+1 617-800-3651
Chris.Ridley@modernatx.com

Investors:

Lavina Talukdar
Senior Vice President & Head of Investor Relations
+1 617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire